Characterization of etoricoxib, a novel, selective COX-2 inhibitor. [electronic resource]
Producer: 20030909Description: 573-85 p. digitalISSN:- 0091-2700
- Adult
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Area Under Curve
- Cyclooxygenase 2
- Dinoprostone -- antagonists & inhibitors
- Double-Blind Method
- Drug Tolerance
- Etoricoxib
- Female
- Gastric Mucosa -- drug effects
- Humans
- Isoenzymes -- antagonists & inhibitors
- Lipopolysaccharides -- antagonists & inhibitors
- Male
- Membrane Proteins
- Middle Aged
- Naproxen -- pharmacology
- Platelet Aggregation -- drug effects
- Prostaglandin-Endoperoxide Synthases
- Pyridines -- blood
- Sulfones -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.